The Medical Advisor

In 2023, Dr Justus Hope reported on a case of Stage IV Colon Cancer that appeared hopeless . The gentleman, Rick, had widespread metastatic disease affecting the liver and lymph nodes and was told his cancer was “unsurvivable.” At most, he had six months left, according to his oncologist. Following adding Ivermectin, his tumor markers dropped from 1489 to 4.7, and his metastases calcified and shrunk. This was believed due to the anti-metastatic effect of Ivermectin as it suppresses the WnT Pathway, which cancer stem cells rely upon.   Dr. Tess Lawrie recently reported on a case of ovarian metastatic cancer with subsequent involvement of the peritoneum – a common spread area. Despite an initial tumor marker (Ca125) level of 288, following Ivermectin and three (9 weeks) chemotherapy sessions, her Ca125 level dropped to 22. There was a substantial regression with no trace of tumor on the peritoneum. Related:  The Surprising Potential of Ivermect...

Dr. Thomas N. Seyfried, PhD, Professor of Biology at Boston College, has been singing the praises of an ancestral diet for treating the modern disease of cancer for years… and with good reason. His theory that cancer is a metabolic disease sounds almost too simplistic, and yet makes perfect sense when you understand what drives cancer’s growth. Standard of Care: The Cut, Poison and Burn Method and Its Miserable Success Record Seyfried is not a fan of conventional medical cancer treatments. As he states in his groundbreaking book, Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer, the majority of today’s health care practitioners are required to prescribe conventional cancer treatments like chemotherapy and radiation—despite their toxicity and the possibility that they encourage new tumor growth. In fact, if a physician does not include these modalities in a treatment plan, the physician may be at risk of losing his medical ...